SCHEMBL5834802

SCHEMBL5834802

CCOC(=O)N(C(=O)Nc1ccc(N(CC)CC)cc1)C1CCc2ccccc2C1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 3/20 0.59
NPY5R Q15761 2/20 0.52
NPY1R P25929 1/20 0.43
NPY2R P49146 1/20 0.43
RAB9A P51151 5/20 0.43
NPC1 O15118 4/20 0.43
NOX1 Q9Y5S8 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
MAPT P10636 3/20 0.41
HTR1A P08908 1/20 0.39
ALDH1A1 P00352 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
GFER P55789 1/20 0.39
MCHR1 Q99705 1/20 0.39
LMNA P02545 2/20 0.38
TP53 P04637 1/20 0.38
NFKB1 P19838 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835382 0.92 GHSR (0.57) GHSRNPY5RNPY1RNPY2RRAB9A
SCHEMBL5835198 0.90 GHSR (0.55) GHSRNPY5RRAB9ANPC1NOX1
SCHEMBL5834860 0.90 GHSR (0.55) GHSRNPY5RNPY1RNPY2RRAB9A
SCHEMBL5834787 0.90 GHSR (0.55) GHSRNPY5RNPY1RNPY2RRAB9A
SCHEMBL5835311 0.90 GHSR (0.55) GHSRNPY5RNPY1RNPY2RRAB9A
SCHEMBL5835145 0.90 GHSR (0.55) GHSRNPY5RNPY1RNPY2RRAB9A
SCHEMBL5835103 0.89 GHSR (0.54) GHSRNPY5RNPY1RNPY2RRAB9A
SCHEMBL5835266 0.89 GHSR (0.54) GHSRNPY5RRAB9ANPC1NOX1
SCHEMBL5834890 0.89 GHSR (0.58) GHSRNPY5RRAB9ANPC1NOX1
SCHEMBL5835034 0.89 GHSR (0.53) GHSRNPY5RNPY1RNPY2RRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US claimed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US claimed
US-7115767-B2 Tetraline derivatives as ghrelin receptor modulators ABBOTT LABORATORIES (US) 2006-10-03 US disclosed
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators ABBVIE INC. 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014794-A1 Tetraline derivatives as ghrelin receptor modulators GPR119, GHSR, GIPR GHSR 2/4885NPY5R 43/4885NPY1R 37/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.